MoneyWorks4Me

Aurobindo Pharma informs about integrated filing

07 Feb 2025 Evaluate

Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No.20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, Aurobindo Pharma has submitted the Integrated Filing (Financial) for the quarter and nine months period ended December 31, 2024. The aforesaid Integrated Filing (Financial) is also being updated on the website of the Company at https://www.aurobindo.com/.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..